Congestion in acute heart failure syndromes: an essential target of evaluation and treatment.
about
Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protectionHeart failure in the Middle EastRelief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute DecompensatedVenous congestion, endothelial and neurohormonal activation in acute decompensated heart failure: cause or effect?Review and Updates in Regenerative and Personalized Medicine, Preclinical Animal Models, and Clinical Care in Cardiovascular Medicine.Use of Lung Ultrasound For Diagnosing Acute Heart Failure in Emergency Department of Southern India.Lung ultrasound: a new tool for the cardiologist.Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow?Pulmonary artery pressure-guided heart failure management: US cost-effectiveness analyses using the results of the CHAMPION clinical trialThe five-point Likert scale for dyspnea can properly assess the degree of pulmonary congestion and predict adverse events in heart failure outpatientsThe cost-effectiveness of real-time pulmonary artery pressure monitoring in heart failure patients: a European perspective.Ambulatory Heart Failure Monitoring: A Systemic ReviewDifferential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction-results of a meta-analysis of randomized controlled trialsNatriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence.Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival.Swine model of chronic postcapillary pulmonary hypertension with right ventricular remodeling: long-term characterization by cardiac catheterization, magnetic resonance, and pathology.Mineralocorticoid receptor antagonists as diuretics: Can congestive heart failure learn from liver failure?Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failureWater and sodium in heart failure: a spotlight on congestionThe short-term and long-term effects of tolvaptan in patients with heart failure: a meta-analysis of randomized controlled trials.Persistent pulmonary congestion before discharge predicts rehospitalization in heart failure: a lung ultrasound study.Loop diuretics in acute heart failure: beyond the decongestive relief for the kidneyHypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart FailureDecongestion in acute heart failure.Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart FailureInfluence of Titration of Neurohormonal Antagonists and Blood Pressure Reduction on Renal Function and Decongestion in Decompensated Heart Failure.Treating volume overload in acutely decompensated heart failure: established and novel therapeutic approachesFinger photoplethysmography during the Valsalva maneuver reflects left ventricular filling pressureRole of diuretics and ultrafiltration in congestive heart failure.Ultrafiltration should not replace diuretics for the initial treatment of acute decompensated heart failure.Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient-parts 1-6.Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestionDoes the bronchial circulation contribute to congestion in heart failure?Clinical and Prognostic Significance of Positive Hepatojugular Reflux on Discharge in Acute Heart Failure: Insights from the ESCAPE Trial.Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure.Registry-Based Pragmatic Trials in Heart Failure: Current Experience and Future Directions.Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care MediTargeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?Tolvaptan for the treatment of heart failure: a review of the literature.Treatment of congestion in heart failure with diuretics and extracorporeal therapies: effects on symptoms, renal function, and prognosis.
P2860
Q26740185-740943FF-C3B0-46AC-AEAE-A3859D0479A3Q26865181-DCDBE3E4-B3FE-4368-92A4-129427FDFABAQ27340297-C66B3229-C970-460C-AB8E-C32414A5240EQ28088361-43F96216-F2F0-4488-87B6-4135010B337EQ30278548-986CF2AB-F098-4E1E-8C43-2A1FA189B92AQ30366194-775B46E3-D5CF-40CE-B039-E06BDDC16EDFQ30476320-ED47CD96-A670-46A2-A5E6-945FFACE5C73Q30724401-82EC58E6-BB57-4F69-9480-2497E37798EFQ30851193-DFDD2721-79E7-4FE8-866A-7C3A6A566139Q33574810-7D9F3BB8-3608-49A8-A92E-F51C72EC3573Q33697820-E04D2082-2FEB-4532-9F6A-DDE87367E21DQ33704427-CE3E73C3-6F4E-467B-9788-DF56015E9364Q33714645-DDD4F39C-A282-450C-B777-2C2C62988D9DQ33862358-85CD850A-D89C-45DA-B1DB-E78925151861Q34512319-E68D78A1-75F3-4B50-842E-B2113B7E3D9BQ35158344-A6A13572-88AC-46D2-BEB4-71AE1DDE9991Q35272248-2D4C4F68-8E7E-42B3-AEB7-B16EE2DA6074Q35285719-CA90AA87-C43F-4667-83D0-419C9454BCCDQ35510429-A98DD0F7-69CF-4CA5-A1B6-9A4C34287AD8Q35763002-C7429AB1-63DC-4792-9A7A-5EA39835106AQ36023194-073C45F9-3D45-4C86-A4AD-0931CCC61165Q36024026-3265C63D-982F-4CAD-9568-F988F1AEC39CQ36254209-C2F31B6A-9C69-4DA9-9921-ACEC2933F75EQ36319066-18B0281A-A99F-4478-AC57-67AB33D92A0FQ36543885-FD5704F4-B4A6-44B7-9079-0859AC7CD6ABQ36543908-E9940516-B1D5-4973-827A-E225A61D7B4FQ37140940-FEFC41D0-8200-41B0-B380-E1F95CFC6817Q37174309-80861B63-9502-45E2-B140-FF1BB2426987Q37277415-D216120D-3EEF-40E8-84A3-2F4EA863FE0BQ37423315-16AFBD44-B068-4700-9434-3904F6F0A1F9Q37461040-B06B87BF-B9E1-4CCC-B1E1-2FE364D559ECQ37480335-45615A93-5C4F-4CFF-8B67-28AC7623B354Q37493519-F61BED09-1918-45BD-8DF7-CD7AB5CF986FQ37683562-55D9D79E-E911-4387-8CCA-548C7A33A184Q37693315-88AA01E9-7814-47C9-9476-DF165EDF502DQ37710165-92DDCEF9-AF2B-4B7D-BD4C-5932BAD2090AQ37721628-972D4CEA-6201-4AE9-BAA3-1CD43CE2AA9BQ37806693-054BDB27-7EE8-4BBE-B165-CE934570D431Q37852720-774E6983-8AB1-4F2C-B37B-061E7354F317Q37874161-C4EAA949-414F-4A18-AFC4-037644A14A3A
P2860
Congestion in acute heart failure syndromes: an essential target of evaluation and treatment.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Congestion in acute heart fail ...... t of evaluation and treatment.
@ast
Congestion in acute heart fail ...... t of evaluation and treatment.
@en
type
label
Congestion in acute heart fail ...... t of evaluation and treatment.
@ast
Congestion in acute heart fail ...... t of evaluation and treatment.
@en
prefLabel
Congestion in acute heart fail ...... t of evaluation and treatment.
@ast
Congestion in acute heart fail ...... t of evaluation and treatment.
@en
P1476
Congestion in acute heart fail ...... t of evaluation and treatment.
@en
P2093
John Burnett
Leonardo De Luca
P304
P356
10.1016/J.AMJMED.2006.09.011
P407
P433
12 Suppl 1
P577
2006-12-01T00:00:00Z